Analysts expect InflaRx N.V. (NASDAQ:IFRX) to report $-0.41 EPS on April, 4.After having $-0.31 EPS previously, InflaRx N.V.’s analysts see 32.26% EPS growth. The stock increased 3.48% or $1.29 during the last trading session, reaching $38.35. About 13,392 shares traded. InflaRx N.V. (NASDAQ:IFRX) has risen 63.49% since March 1, 2018 and is uptrending. It has outperformed by 63.49% the S&P500. Some Historical IFRX News: 03/05/2018 – INFLARX PRIMARY, SECONDARY OFFERINGS PRICES AT $34.00 PER SHARE; 29/03/2018 – InflaRx Full Year 2017 Financial & Operating Results; 08/03/2018 – lnflaRx announces first patient enrolled in Phase llb trial with lead candidate IFX-1 in Hidradenitis Suppurativa; 08/03/2018 – INFLARX ANNOUNCES FIRST PATIENT ENROLLED IN PHASE llB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA; 08/05/2018 – InflaRx N.V. Announces Closing of Primary and Secondary Offering of Common Shrs; 17/05/2018 – INFLARX NV – CASH POSITION APPROXIMATELY US$137 MLN (EUR 115 MLN) AS OF MARCH 31, 2018; 08/03/2018 InflaRx announces first patient enrolled in Phase IIb trial with lead candidate IFX-1 in Hidradenitis Suppurativa; 29/03/2018 – lnflaRx Full Year 2017 Financial & Operating Results; 17/05/2018 – InflaRx 1Q Loss/Shr EUR0.04; 08/05/2018 – INFLARX N.V. REPORTS CLOSING OF PRIMARY, SECONDARY OFFERING
Among 3 analysts covering American Water Works Co (NYSE:AWK), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. American Water Works Co had 8 analyst reports since September 17, 2018 according to SRatingsIntel. The stock of American Water Works Company, Inc. (NYSE:AWK) earned “Outperform” rating by Wells Fargo on Wednesday, December 12. The stock of American Water Works Company, Inc. (NYSE:AWK) earned “Hold” rating by Bank of America on Thursday, February 21. Robert W. Baird upgraded American Water Works Company, Inc. (NYSE:AWK) on Thursday, December 6 to “Outperform” rating. Robert W. Baird maintained American Water Works Company, Inc. (NYSE:AWK) on Wednesday, December 12 with “Outperform” rating. See American Water Works Company, Inc. (NYSE:AWK) latest ratings:
26/02/2019 Broker: BidaskScore Rating: Buy Upgrade
21/02/2019 Broker: Bank of America Rating: Hold New Target: $103 Maintain
20/02/2019 Broker: Wells Fargo Rating: Buy Maintain
20/02/2019 Broker: Boenning & Scattergood Rating: Hold Maintain
12/12/2018 Broker: Wells Fargo Old Rating: Outperform New Rating: Outperform Old Target: $97 New Target: $104 Maintain
12/12/2018 Broker: Robert W. Baird Old Rating: Outperform New Rating: Outperform Old Target: $103 New Target: $104 Maintain
06/12/2018 Broker: Robert W. Baird Old Rating: Neutral New Rating: Outperform New Target: $103 Upgrade
17/09/2018 Broker: Evercore Rating: Outperform New Target: $96 Initiates Coverage On
More notable recent American Water Works Company, Inc. (NYSE:AWK) news were published by: Seekingalpha.com which released: “American Water Works Q4 2018 Earnings Preview – Seeking Alpha” on February 18, 2019, also Gurufocus.com with their article: “Caxton Associates Adds to Amazon, Alibaba, AIG – GuruFocus.com” published on February 25, 2019, Businesswire.com published: “American Water Earns Four ‘Military Friendly Employer’ Designations for 2019 – Business Wire” on February 18, 2019. More interesting news about American Water Works Company, Inc. (NYSE:AWK) were released by: Businesswire.com and their article: “Illinois American Water’s Champaign County District Wins Regional Water Taste Test – Business Wire” published on February 25, 2019 as well as 247Wallst.com‘s news article titled: “Top Analyst Upgrades and Downgrades: Agilent, American Water, Apple, Biogen, Garmin, GoDaddy, Tilray, UBS, Walmart and More – 24/7 Wall St.” with publication date: February 21, 2019.
Since September 5, 2018, it had 1 buying transaction, and 2 insider sales for $1.35 million activity. STORY SUSAN N bought 96 shares worth $8,823. $458,450 worth of American Water Works Company, Inc. (NYSE:AWK) was sold by Lynch Walter on Thursday, November 15.
The stock decreased 0.44% or $0.45 during the last trading session, reaching $101.17. About 116,529 shares traded. American Water Works Company, Inc. (NYSE:AWK) has risen 7.00% since March 1, 2018 and is uptrending. It has outperformed by 7.00% the S&P500. Some Historical AWK News: 21/05/2018 – Water Quality Reports Show Illinois American Water Continues to Deliver Water That Meets, or is Better Than, Drinking Water Standards; 12/04/2018 – AMERICAN WATER WORKS COMPANY – AFFIRMS 2018 EPS GUIDANCE RANGE OF $3.22 – $3.32; 13/04/2018 – Illinois American Water Announces Agreement To Acquire Alton’s Regional Wastewater System; 11/04/2018 – After-hours buzz: BBBY, ZUMZ, AWK & more; 11/05/2018 – American Water Works Appoints Director Karl Kurz as Chairman of Board; 19/03/2018 – West Virginia American Water Reminds Customers That Each Drop Adds up During Fix a Leak Week; 01/04/2018 – Virginia American Water LIFTS Boil Water Advisory for Customers in Hopewell District; 16/05/2018 – American Water’s Vallejo to Participate in Betterlnvesting National Convention; 12/04/2018 – AMERICAN WATER WORKS COMPANY INC AWK.N FY2018 SHR VIEW $3.28 — THOMSON REUTERS l/B/E/S; 13/04/2018 – Illinois American Water Announces Agreement to Acquire Alton’s Regional Wastewater System
Investors sentiment decreased to 0.97 in 2018 Q3. Its down 0.16, from 1.13 in 2018Q2. It dived, as 38 investors sold American Water Works Company, Inc. shares while 192 reduced holdings. 61 funds opened positions while 163 raised stakes. 139.95 million shares or 3.96% less from 145.72 million shares in 2018Q2 were reported. The Pennsylvania-based Brinker Inc has invested 0.03% in American Water Works Company, Inc. (NYSE:AWK). Stevens Cap Mgmt L P owns 0.03% invested in American Water Works Company, Inc. (NYSE:AWK) for 10,210 shares. Fort Washington Investment Advsrs Oh has 101,177 shares for 0.09% of their portfolio. Panagora Asset Inc accumulated 32,988 shares. Pennsylvania Tru invested in 0.13% or 36,552 shares. Osterweis Mgmt has invested 1.42% in American Water Works Company, Inc. (NYSE:AWK). Trexquant Investment L P has 0.03% invested in American Water Works Company, Inc. (NYSE:AWK) for 5,068 shares. Livingston Grp Inc Asset Co (Operating As Southport Capital Management) reported 5,366 shares. Kansas-based Cognios Capital Ltd Limited Liability Company has invested 0.15% in American Water Works Company, Inc. (NYSE:AWK). Intact Invest Management owns 0.16% invested in American Water Works Company, Inc. (NYSE:AWK) for 52,300 shares. Zeke Ltd Com reported 0.02% stake. Dimensional Fund Limited Partnership reported 453,419 shares. Ameriprise reported 1.08 million shares stake. Retirement System Of Alabama holds 0.03% or 83,237 shares. 10,600 were accumulated by Telemus Cap Ltd Liability Corp.
American Water Works Company, Inc., through its subsidiaries, provides water and wastewater services in the United States and Canada. The company has market cap of $18.29 billion. The firm offers water and wastewater services to approximately 1,600 communities in 16 states. It has a 32.12 P/E ratio. It operates approximately 81 surface water treatment plants with approximately 522 groundwater treatment plants and 1,022 groundwater wells; 121 wastewater treatment facilities, 1,284 treated water storage facilities, 1,433 pumping stations, 80 dams, and 49,635 miles of mains and collection pipes.
More notable recent InflaRx N.V. (NASDAQ:IFRX) news were published by: Globenewswire.com which released: “Richard Brudnick to Join InflaRx Board of Directors – GlobeNewswire” on February 14, 2019, also Nasdaq.com with their article: “Telesat Reports Results for the Quarter and Year Ended December 31, 2018 – Nasdaq” published on March 01, 2019, Globenewswire.com published: “Market Trends Toward New Normal in Nuance Communications, Fate Therapeutics, Hamilton Lane, InflaRx NV, Enerplus, and ManTech International â€” Emerging Consolidated Expectations, Analyst Ratings – GlobeNewswire” on February 25, 2019. More interesting news about InflaRx N.V. (NASDAQ:IFRX) were released by: Nasdaq.com and their article: “Mithra Reports 2018 Annual Results – Nasdaq” published on March 01, 2019 as well as Globenewswire.com‘s news article titled: “InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa – GlobeNewswire” with publication date: February 06, 2019.
InflaRx N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology primarily in the United States and Europe. The company has market cap of $984.14 million. The Company’s C5a is an inflammatory mediator involved in the enhancement of a variety of autoimmune and other inflammatory diseases. It currently has negative earnings. The company’s lead product candidate is IFX-1, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that is in the Phase IIb clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; to treat ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and for the treatment of other chronic/autoimmune diseases.